Dr. Abdulkarim Alhetheel Assistant Professor College of Medicine & KKUH Viral hepatitis (B, C, D, G)
Using m-health strategies to improve laboratory data management in PMTCT programs m-health satellite Washington, July 23, 2012.
Tto vih
Hepatitis b
CONGENITAL CYTOMEGALOVIRUS Learning Objectives Introduction Congenital Infections Microbiology Epidemiology Clinical Features Clinical Findings and DeficitsClinical.
Phase 1/2, Multicenter, Open-label, Pharmacokinetic, Safety, Tolerability, and Antiviral Activity Study of Dolutegravir (DTG), a Novel Integrase Inhibitor,
Hepatitis in Pregnancy. Summary of physiological changes in the liver during pregnancy Increased: Blood volume and cardiac ouput rise by 35% – 50% Alkaline.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria.
Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E,
International Symposium Centenary of Chagas Disease 1909. 2009 Use of Polymerase Chain Reaction (PCR) to Establish Drug Efficacy - Value and Limitations.
Chagas Disease in the United States FDA BPAC meeting, 1 April 2009 Susan P. Montgomery, DVM MPH LCDR, USPHS Parasitic Diseases Branch Centers for Disease.
